R2 Technologies, Inc.

R2 Technologies, Inc. manufactures Glacial Skin, a proprietary line of CryoAesthetics devices that use patented Cryomodulation technology for skin rejuvenation and inflammation management. The company's primary product platforms—Glacial Rx and Glacial fx—deliver controlled cooling treatments to address premature aging, redness, rosacea, melasma, and post-procedure inflammation. Specific treatment protocols include Glacial Gloss Rx (exfoliation and cooling for tone and texture), Glacial Glide Rx (cooling for facial and body inflammation reduction, pain, and swelling), Glacial Glide Rx Combinations (post-laser and post-procedure recovery), and Glacial Freeze (spot cryotherapy for benign lesions and pigmentation). The devices are FDA-cleared and safe for all skin types without numbing or downtime. Clinical data demonstrate 100% patient repeat/recommend rate, 90% reporting brighter/rejuvenated skin at one month, and 92% showing physician-verified improvement. R2 Technologies targets aesthetic practices, medical spas, dermatology clinics, and laser centers, offering comprehensive provider support including training, marketing tools, and protocol development to maximize practice revenue and patient outcomes.